NCT02389595View on ClinicalTrials.gov

Selection of a Protective T Cell-based HIV-1/FIV Vaccine

Active, not recruitingOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
HIV
Interventions
OTHER

HIV positive subjects

This group will provide a blood sample.

OTHER

Non-infected control subjects

This group will be de-identified blood samples from a commercial source.

Trial Locations (2)

32209

UF Center for AIDS Research Education and Service, Jacksonville

32611

University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT02389595 - Selection of a Protective T Cell-based HIV-1/FIV Vaccine | Biotech Hunter | Biotech Hunter